The Co-Founder and CEO of Philadelphia based BioPhy describes how he sees AI playing out across the biopharma landscape

blonca9
Jul 11, 2024
1 min read

Dave Latshaw II predicts how AI might affect organizations of different sizes in biopharma and explains the various ways BioPhy is using it today to help companies.

Recent Posts

See All

Microsoft's Chief Scientific Officer for Health and Life Sciences shares his take on how AI is changing healthcare today and what is possible in the future

Klein Hersh at #ASCO25

Deerfield Management Managing Partner James Flynn discusses a new $600M venture fund the firm has raised and describes how it will be invested, including into AI companies

The Co-Founder and CEO of Philadelphia based BioPhy describes how he sees AI playing out across the biopharma landscape

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight